Aims Smoking prevalence is higher among people enrolled in addiction treatment compared
with the general population, and very high rates of smoking are associated with opiate drug …

Aims This paper reviews the published literature regarding outcomes following maternal
treatment with buprenorphine in five areas: maternal efficacy, fetal effects, neonatal effects …

This article provides an overview and discussion of the collective maternal, fetal and
neonatal outcome research on women maintained on methadone or buprenorphine during …

Importance The number of children with prenatal opioid exposure to medication for addiction
treatment (MAT) with methadone and buprenorphine for maternal opioid use disorder is …

OBJECTIVE:: The purpose of this study was to examine the relationship among methadone
maintenance treatment, perinatal outcomes, and neonatal abstinence syndrome. STUDY …

Aim To identify factors that predict the expression of neonatal abstinence syndrome (NAS) in
infants exposed to methadone or buprenorphine in utero. Design and Setting Multi‐site …

Prenatal opioid exposure has reached epidemic proportions. In the last 10 years, there has
been a 242% increase in the number of babies born with the drug withdrawal syndrome …

Background The relationship between cigarette smoking and neonatal and maternal clinical
outcomes among opioid-agonist-treated pregnant patients is sparse. Objectives (1) Is …

Poor birth outcomes are associated with illicit drug use during pregnancy. While prenatal
cigarette exposure has similar effects, cessation of illicit drug use during pregnancy is often …

Background Intrauterine exposure to antidepressants may lead to neonatal symptoms from
the central nervous system, respiratory system and gastrointestinal system. Finnegan score …